Trial Profile
Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2007-2008 Formulation (Intramuscular Route).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2014
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sanofi
- 12 Jul 2007 New trial record.